Cover Image

CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease

Abstract The endocannabinoid CB2 receptor system has been implicated in the neuropathology of Alzheimer's disease (AD). In order to investigate the impact of the CB2 receptor system on AD pathology, a colony of mice with a deleted CB2 receptor gene, CNR2, was established on a transgenic human m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jeremy Koppel (Author), Valerie Vingtdeux (Author), Philippe Marambaud (Author), Cristina d'Abramo (Author), Heidy Jimenez (Author), Mark Stauber (Author), Rachel Friedman (Author), Peter Davies (Author)
Format:	Book
Published:	BMC, 2013-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anesthesia promotes acute expression of genes related to Alzheimer's disease and latent tau aggregation in transgenic mouse models of tauopathy
by: John David Eun, et al.
Published: (2022)

Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease
by: Samuel Ruiz de Martín Esteban, et al.
Published: (2022)

Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans
by: Marina Han, et al.
Published: (2024)

The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer’s Disease
by: Yan H, et al.
Published: (2023)

Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease
by: Chang Qu, et al.
Published: (2023)

Lentivirus-Carried microRNA-195 Rescues Memory Deficits of Alzheimer's Disease Transgenic Mouse by Attenuating the Generation of Amyloid Plaques
by: Dan Su, et al.
Published: (2021)

A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides
by: Valérie Vingtdeux, et al.
Published: (2016)

Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig
by: Vanessa J. Hall, et al.
Published: (2015)

Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy
by: Ryszard Pluta, et al.
Published: (2022)

Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: A potential therapeutic for Alzheimer's disease
by: Oliver B. Villaflores, et al.
Published: (2012)

Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation
by: Marine Tournissac, et al.
Published: (2019)

Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
by: Ivan Carrera, et al.
Published: (2014)

Effect of policosanol from insect wax on amyloid β-peptide-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer's disease
by: Xin Zhang, et al.
Published: (2021)

Centella asiatica Alters Metabolic Pathways Associated With Alzheimer's Disease in the 5xFAD Mouse Model of ß-Amyloid Accumulation
by: Alex B. Speers, et al.
Published: (2021)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
by: Caitlin V. M. L. Jie, et al.
Published: (2021)

Ursolic acid and rosmarinic acid ameliorate alterations in hippocampal neurogenesis and social memory induced by amyloid beta in mouse model of Alzheimer's disease
by: Fatima Javed Mirza, et al.
Published: (2022)

Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer's Disease
by: Simi Zhang, et al.
Published: (2024)

Maternal sevoflurane exposure induces neurotoxicity in offspring rats via the CB1R/CDK5/p-tau pathway
by: Yuxiao Wan, et al.
Published: (2023)

Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration
by: Shenée C. Martin, et al.
Published: (2024)

MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation via Coregulating BACE1 and PRKACB
by: Linlin Wang, et al.
Published: (2019)

Amyloid-beta clearance in Alzheimer's disease
by: Robert Marr
Published: (2015)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer's Disease
by: Heeyoung Kang, et al.
Published: (2021)

Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
by: Taweesak Tangrodchanapong, et al.
Published: (2020)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease
by: A. Claudio Cuello, et al.
Published: (2019)

Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease
by: Sha Liu, et al.
Published: (2016)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018)

EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy
by: Yanjing Zhu, et al.
Published: (2023)

Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models
by: Jang Woo Park, et al.
Published: (2024)

β-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer's Disease
by: Xiaojuan eSun, et al.
Published: (2015)

PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease
by: Peter Bloomingdale, et al.
Published: (2022)

INFLUÊNCIA DAS PROTEÍNAS BETA AMILOIDE E TAU NA DOENÇA DE ALZHEIMER
by: Fausto Pierdoná Guzen, et al.
Published: (2012)

Ginsenoside Rd protects transgenic Caenorhabditis elegans from β-amyloid toxicity by activating oxidative resistant
by: Lihan Mi, et al.
Published: (2022)

Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β- Amyloid Toxicity
by: Xiao-Gang Zhang, et al.
Published: (2016)

NVP-BEZ235 (Dactolisib) Has Protective Effects in a Transgenic Mouse Model of Alzheimer's Disease
by: Paula Maria Quaglio Bellozi, et al.
Published: (2019)

Brexpiprazole: A new option in treating agitation in Alzheimer's dementia-Insights from transgenic mouse models
by: Naoki Amada, et al.
Published: (2024)

Increased neutrophils in inflammatory bowel disease accelerate the accumulation of amyloid plaques in the mouse model of Alzheimer's disease
by: Ryusei Kaneko, et al.
Published: (2023)

The cost and benefit of targeting amyloid plaques to treat alzheimer's disease
by: Marisa E Franklin, et al.
Published: (2023)

Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and Neuroinflammation
by: Claudia Balducci, et al.
Published: (2019)

Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
by: Mei Wang, et al.
Published: (2024)

Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients
by: Lidia Blazquez-Llorca, et al.
Published: (2010)